Understanding the Experience of Patients With Early-Stage Cancers: A Targeted Qualitative Literature Review

Author(s)

Roberts A1, Aguiar-Ibáñez R2, Trennery C1, Kendal H3, Shah H1, Rees H1, Arbuckle R1, McQuarrie K4
1Adelphi Values Ltd, Bollington, Cheshire, UK, 2Merck & Co., Inc., Toronto, ON, Canada, 3Adelphi Values Ltd, Read, UK, 4Merck & Co., Inc., Rahway, NJ, USA

OBJECTIVES: Health-related quality of life (HRQoL) is anticipated to be better in patients with early-stage cancer compared with those with advanced disease. However, there is limited understanding of the patient experience (i.e., symptoms, HRQoL impacts) of early-stage cancers. This study aimed to synthesize existing qualitative literature describing the patient experience of early-stage breast, renal cell carcinoma (RCC), bladder, head and neck, melanoma, non-small cell lung cancer (NSCLC), and endometrial cancers and develop preliminary conceptual models of the patient experience in these populations.

METHODS: A targeted literature search was conducted in OVID SP® (MEDLINE®, Embase®, PsycINFO®). Qualitative or mixed-methods studies describing the patient experience of at least one out of seven early-stage cancers were included. Relevant concepts were identified, extracted and categorized into domains, to form preliminary conceptual models.

RESULTS: Forty-eight articles across six early-stage cancers were extracted. Most of the studies included early-stage breast cancer patients (n=23 articles) and no literature for RCC was identified. A diverse range of disease-related signs/symptoms (n=40), HRQoL impacts (n=52), treatment-related symptoms (n=25) and HRQoL impacts (n=25) were identified. Pain (n=27 articles) and fatigue (n=18 articles) (both as disease- and treatment-related symptoms) were most commonly reported across cancer types. Other signs/symptoms corresponded with the specific cancer site (e.g., dermatological symptoms in melanoma). Psychological/emotional impacts (e.g. worry/anxiety, fear of recurrence/diagnosis/dying, low mood/depression, low self-esteem/confidence due to treatment) were most frequently reported across cancers (n=38 articles). The conceptual models outline the cancer types and number of sources each concept was identified in.

CONCLUSIONS: Despite improved survival outcomes associated with early-stage disease, these findings demonstrate the significant burden of diagnosis and treatment of early-stage cancers, particularly with regards to fatigue, pain, and psychological impacts. Further qualitative research may help confirm the most salient concepts in early-stage cancers, particularly in cancers where evidence is lacking (e.g. RCC).

Conference/Value in Health Info

2024-11, ISPOR Europe 2024, Barcelona, Spain

Value in Health, Volume 27, Issue 12, S2 (December 2024)

Code

PCR262

Topic

Patient-Centered Research

Topic Subcategory

Instrument Development, Validation, & Translation, Patient-reported Outcomes & Quality of Life Outcomes

Disease

No Additional Disease & Conditions/Specialized Treatment Areas, Oncology

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×